These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11205844)
1. Treatment of superior vena cava syndrome with recombinant tissue plasminogen activator in a sickle cell patient undergoing bone marrow transplantation. Ramdas J; Haymon M; Ward K; Velez M; Yu LC Pediatr Hematol Oncol; 2001; 18(1):71-7. PubMed ID: 11205844 [TBL] [Abstract][Full Text] [Related]
2. Superior vena cava syndrome arising from subclavian vein port catheter implantation and paraneoplastic syndrome. Dağdelen S Turk Kardiyol Dern Ars; 2009 Mar; 37(2):125-7. PubMed ID: 19404035 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis. Simpson DR; Browett PJ; Doak PB; Palmer SJ Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540 [TBL] [Abstract][Full Text] [Related]
4. [Use of recombinant tissue plasminogen activator (rt-PA) in occluding thrombosis of a Hickman catheter after bone marrow transplantation: clinical and coagulation physiologic aspects]. Eckhof-Donovan S; Michelmann I; Nürnberger W; Stieh J; Rost B; Kemperdick H; Göbel U Klin Padiatr; 1993; 205(6):435-9. PubMed ID: 8309209 [TBL] [Abstract][Full Text] [Related]
5. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator]. Schranz D; Haugwitz D; Zimmer B; Schumacher R Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943 [TBL] [Abstract][Full Text] [Related]
6. Use of tissue type plasminogen activator in neonates: case reports and review of the literature. Smets K; Vanhaesebrouck P; Voet D; Schelstraete P; Govaert P Am J Perinatol; 1996 May; 13(4):217-22. PubMed ID: 8724722 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile. Goldberg SL; Shubert J; Rao AK; Redei I; Klumpp TR; Mangan KF Bone Marrow Transplant; 1996 Sep; 18(3):633-6. PubMed ID: 8879629 [TBL] [Abstract][Full Text] [Related]
8. Superior vena cava syndrome (SVC syndrome): a rare cause of conjunctival suffusion. Saeed AI; Schwartz AP; Limsukon A Mt Sinai J Med; 2006 Dec; 73(8):1082-5. PubMed ID: 17285199 [TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic treatment of superior vena cava syndrome, a complication of a central venous catheter]. Wolters J; Berg H; Zeidler T Anaesthesist; 1989 Jan; 38(1):40-3. PubMed ID: 2919751 [TBL] [Abstract][Full Text] [Related]
10. "The Scalpel or the Needle for Superior Vena Cava syndrome"? Chandra D; Pothineni NV; Meena N J Ark Med Soc; 2015 Aug; 112(3):34-5. PubMed ID: 26376553 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients. Leahey AM; Bunin NJ Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121 [TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis. Tan H; Kizilkaya M; Alper F; Becit N; Kürşat H Acta Paediatr; 2005 Feb; 94(2):239-41. PubMed ID: 15981762 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic (rt-PA) therapy for superior vena cava thrombosis in a multiple trauma patient. Imberti R; Albertario F; Bellinzona G; Dionigi RV; Preseglio I; Mapelli A Acta Anaesthesiol Belg; 1991; 42(4):233-6. PubMed ID: 1796733 [TBL] [Abstract][Full Text] [Related]
14. [Iatrogenic superior vena cava syndrome. Successful thrombolysis with recombinant tissue plasminogen activator (r-tPA)]. Sternlo JE; Askelöf N Lakartidningen; 1992 Jan; 89(4):214-5. PubMed ID: 1734155 [No Abstract] [Full Text] [Related]
15. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions. Mathur M; Desai N; Sharma J; Rao SP; Goldman GM Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of superior vena cava syndrome with urokinase in an infant with a central venous catheter. Caglar MK; Tolboom J Helv Paediatr Acta; 1989 Jun; 43(5-6):483-6. PubMed ID: 2501237 [TBL] [Abstract][Full Text] [Related]
17. Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate. Patton DF; Harper JL; Wooldridge TN; Gordon BG; Coccia P; Haire WD Bone Marrow Transplant; 1996 Mar; 17(3):443-7. PubMed ID: 8704704 [TBL] [Abstract][Full Text] [Related]
18. Treatment of superior vena cava (SVC) syndrome and inferior vena cava (IVC) thrombosis in a patient with colorectal cancer: combination of SVC stenting and IVC filter placement to palliate symptoms and pave the way for port implantation. Sauter A; Triller J; Schmidt F; Kickuth R Cardiovasc Intervent Radiol; 2008 Jul; 31 Suppl 2():S144-8. PubMed ID: 17605068 [TBL] [Abstract][Full Text] [Related]
19. Thrombosis of the superior vena cava due to a Hickman catheter: successful management by rt-PA thrombolysis. Zaccone G; Pafundi PD; Veneziani A; Verbo A; Colli R J Vasc Access; 2017 Nov; 18(6):e92-e94. PubMed ID: 28777397 [TBL] [Abstract][Full Text] [Related]
20. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator. Greenberg S; Kosinski R; Daniels J Chest; 1991 May; 99(5):1298-301. PubMed ID: 1902161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]